Streetbeat News

CURLF

Curaleaf Holdings Inc

Employees

5,138

Industry

Medicinal and Botanical Manufacturing

Open

2.20

Mkt cap

1.7B

Volume

124K

High

2.25

P/E Ratio

-7.93

52-wk high

6.40

Low

2.08

Div yield

N/A

52-wk low

1.64

Curaleaf Holdings, Inc. stock has dropped significantly post-election, but potential support for cannabis regulations from the Trump administration could offer upside. Despite financial stress, Curaleaf's size and international growth present long-term potential.

Portfolio Pulse from

November 15, 2024 | 5:30 pm

Curaleaf Holdings, Inc. (CURLF) reported a Q3 loss of $0.07 per share, missing the Zacks Consensus Estimate of a $0.06 loss. This is an improvement from the $0.09 loss per share a year ago.

Portfolio Pulse from

November 07, 2024 | 12:00 am

Curaleaf Holdings, Inc. has secured a new $40 million revolving credit facility to support its working capital needs.

Portfolio Pulse from

November 06, 2024 | 9:30 pm

Curaleaf Holdings reported a slight decrease in Q3 2024 revenue to $331 million, with a 49% adjusted gross margin. International revenue saw a significant 82% increase year-over-year. The company secured a $40 million revolving credit facility at a 7.99% interest rate.

Portfolio Pulse from

November 06, 2024 | 9:30 pm

Microsoft shares rise as the company reports better-than-expected Q1 2025 GAAP EPS and sales.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 8:05 pm

Arizona will allow adult-use cannabis deliveries starting November 1, expanding access beyond medical marijuana patients. This move is expected to boost consumer convenience, job creation, and economic development. Companies like Curaleaf Holdings and Trulieve Cannabis Corp. may benefit from increased demand.

Portfolio Pulse from Patricio Liddle

October 30, 2024 | 12:53 pm

On October 29, 2024, several cannabis-related stocks experienced significant price movements. Currenc Group (NASDAQ:CURR) and Encompass Health (NYSE:EHC) were among the gainers, while Eastside Distilling (NASDAQ:EAST), 22nd Century Group (NASDAQ:XXII), Cara Therapeutics (NASDAQ:CARA), Greenlane Holdings (NASDAQ:GNLN), and Urban-gro (NASDAQ:UGRO) were among the losers.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 8:30 pm

A study by Curaleaf Clinic reveals that 90% of illegal cannabis samples in the UK contain harmful contaminants. Curaleaf Holdings, the parent company, is using this data to advocate for awareness and regulation. The study highlights the health risks of illegal cannabis and the potential economic benefits of legal medical cannabis prescriptions.

Portfolio Pulse from Nina Zdinjak

October 28, 2024 | 12:46 pm

Florida's cannabis market is poised for significant changes with the upcoming recreational cannabis vote. The market is experiencing deflation, with sales dropping despite volume growth, and a competitive landscape is emerging. Key players like Trulieve, Verano, and AYR are expanding retail operations, while M&A activity is expected to increase. Companies like AYR and iAnthus may become acquisition targets due to financial challenges, while others like Green Thumb and Curaleaf are positioned to acquire assets. If recreational cannabis is legalized, the market could triple, offering substantial growth opportunities.

Portfolio Pulse from Nicolás Jose Rodriguez

October 26, 2024 | 6:15 pm

B NOBLE, founded by Fab 5 Freddy, is collaborating with Greenbook Academy to offer 100 free job training grants in Florida, focusing on cannabis trimming and dispensary technician training. This initiative aims to empower minorities and aspiring professionals in the cannabis industry. B NOBLE, in partnership with Curaleaf, is committed to social equity and supporting communities historically impacted by punitive cannabis laws. Curaleaf's SVP, Kate Smith, highlights the company's alignment with B NOBLE's goals and its commitment to diversity and social equity in cannabis.

Portfolio Pulse from Patricio Liddle

October 25, 2024 | 8:51 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.